Chromosome 19p13.13 deletion syndrome, also known as 19p13.13 microdeletion syndrome, is a rare chromosomal disorder resulting from a partial deletion on chromosome 19 at band p13.13. It is classified as a partial autosomal monosomy and is primarily characterized by global developmental delay, moderate intellectual disability, macrocephaly, overgrowth, and hypotonia. Distinctive facial features, including frontal bossing and down-slanting palpebral fissures, are also commonly observed. Because this condition is very rare, affecting fewer than 1 in 1 million people, diagnosis relies on detailed clinical and genetic evaluation.

Individuals with chromosome 19p13.13 deletion syndrome typically present with significant developmental challenges, including global developmental delay and moderate intellectual disability. Common clinical features include macrocephaly, overgrowth, hypotonia, and distinctive facial dysmorphism marked by frontal bossing and down-slanting palpebral fissures. In addition, some affected individuals may experience ataxia, seizures, ventriculomegaly, ocular abnormalities such as strabismus and optic nerve hypoplasia, and gastrointestinal issues like abdominal pain, vomiting, or constipation. Not all individuals experience all features, and severity varies considerably.

The precise genetic basis of chromosome 19p13.13 deletion syndrome is still under investigation, although it is understood to result from a deletion affecting a segment on chromosome 19. Since no specific genes have been definitively linked in the current data, the condition is thought to involve complex genetic factors rather than a single gene defect. Inheritance patterns have not been clearly established, and most cases appear to be sporadic. Families are encouraged to seek genetic counseling to better understand any potential recurrence risks and the overall genetic implications.